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Based on data from the Indonesian 
Ministry of Health Information Center, the 
estimated population of Indonesia in 2016 was 
approximately 258,704,986 people, consisted 
of 129,988,690 men and 128,716,296 women.1 
This number of Indonesian population represents 
young population since the proportion of 
population aged 0-14 years is more than that 
aged >14 years. Meanwhile, the proportion 
of population aged 50 years and above is 
significantly reduced, which is thought to be 
due to high mortality rate in the middle-aged 
population. The mortality rate in  Indonesia 
is dominated by non-communicable diseases 
(NCD).1,2 Alteration in environment, technology 
and lifestyle have changed the pattern of disease 
in Indonesia to be dominated by NCD such as 
DM, heart disease, dyslipidemia, obesity, kidney 
disease, lung disease, and malignancy.1,2
According to the 2014 Indonesian Sample 
Registration System, the 10 most common 
diseases were stroke (21.1%), heart disease 
(12.9%), diabetes mellitus (6.7%), tuberculosis 
(5.7%), complications of high blood pressure 
(5.3%), chronic lung disease (4.9%), liver disease 
(2.7%), traffic accidents (2.6%), pneumonia 
(2.1%), and combined diarrhea and gastroenteritis 
due to infection (1.9%).1,2 Furthermore, according 
to Indonesia Basic Health Research 2018, most 
of NCD such as cancer, stroke, kidney disease, 
joint disease, DM, heart disease, hypertension, 
and overweight/ obesity, showed an increasing 
trend compared to the previous report in 2013.3 
Non-communicable diseases are chronic, 
often asymptomatic and progressive, thus patients 
usually did not realize having the disease until the 
sign and symptoms of its complications occur. 
This problem drives the need of early screening 
for high-risk population, early treatment and 
periodic monitoring. Furthermore, ongoing 
epidemiological studies are also done to 
evaluate both established and unknown risk 
factors, pattern of non-communicable disease 
development in certain area and the treatment 
response.4
Recent edition included researches about 
NCD such as atherosclerosis in diabetes, diabetes 
nephropathy, malignancy, musculoskeletal 
disorders, and chronic kidney disease. 
Atherosclerosis and nephropathy are chronic 
complications in type-2 diabetes mellitus. 
About three-quarters of the cause of death in 
diabetic patients is coronary heart disease, one 
of the progressive atherosclerosis processes. 
Traditional risk factors such as sedentary 
lifestyles, obesity, high-calorie diets, smoking, 
and history of family diseases, as well as non-
traditional risk factors such as inflammation have 
been shown to play a role in the progression 
of atherosclerosis and cause ischemic vascular 
disease such as stroke, coronary heart disease 
and peripheral artery disease.5 The linkages of 
chronic inflammation (periodontitis) that are 
often experienced by diabetic patients with 
progression of atherosclerosis was demonstrated 
by the previous studies with varying results. 
In addition, research at the molecular level 
that evaluates the relationship between certain 
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gene polymorphisms and disease events seeks 
to map the risk of disease progression based 
on the distribution of polymorphisms. Gene 
polymorphisms researches also drive the 
improvement of health technology such as 
prediction of disease prognosis, identification 
of drugs candidate and prediction of treatment 
failure.6 Topic of disease prevention are also 
investigated starting with detecting early 
metabolic abnormalities in the relatives of 
patients with certain metabolic diseases such 
as diabetes, heart disease and polycystic ovary 
syndrome.
Besides cardiovascular disease, the 
prevalence of malignancy in Indonesia has 
also been increasing. The correlation between 
metabolic disorders and malignancy had been 
studied intensively.7 Among particular population 
who had family history of malignancy, chronic 
inflammation state is thought to promote 
proinflammatory cytokines-induced cell 
dysregulation. Since diabetes and obesity are 
known as chronic inflammation, both diseases 
are believed and proven to be involved in certain 
malignancy process. Numerous cohort studies 
summarized in systematic reviews have shown 
a link between obesity and cancer incidence, for 
both overall and for selected cancer sites (eg, 
endometrial, postmenopausal breast, colon, and 
esophageal adenocarcinoma).7
Finally, the increase of NCD worldwide 
potentially give serious impact on health cost 
and quality of life. Prevention of risk factors 
contributing to NCD should be the main priority 
in National Health Program to reduce the 
prevalence of NCD in the future.
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